Literature DB >> 2088401

AIDS and HIV infection in Uganda--are more women infected than men?

S Berkley1, W Naamara, S Okware, R Downing, J Konde-Lule, M Wawer, M Musagaara, S Musgrave.   

Abstract

In countries in sub-Saharan Africa, HIV is transmitted primarily heterosexually. HIV infection and AIDS in women not only affects women's health but also has implications for the other members of society. Maternal infection is the source of most childhood HIV infection in Africa and maternal health is a strong predictor of child survival. In Uganda, a review of passive AIDS surveillance has shown almost equal numbers of clinical cases reported in men and women. However, in three population-based HIV serosurveys, women were consistently found to have a higher infection rate (approximately 1.4 times) than men. In addition, both AIDS case surveillance and seroprevalence studies demonstrate an earlier age of presentation and mean age of infection in women. The higher rate of HIV infection in women suggests either differential rates of transmission between women and men, higher rates of female sexual exposure to infected men, or longer survival among HIV-infected women compared with men. Although further studies are required to illuminate both the biology and the epidemiology of heterosexual HIV transmission in Africa, these findings of earlier and higher infection rates in women have important implications for women's health and child survival in Uganda and indicate the need for specially targeted interventions to reduce transmission in this group.

Entities:  

Mesh:

Year:  1990        PMID: 2088401     DOI: 10.1097/00002030-199012000-00009

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  10 in total

Review 1.  Impact of the HIV epidemic on population and household structure: the dynamics and evidence to date.

Authors:  Patrick Heuveline
Journal:  AIDS       Date:  2004-06       Impact factor: 4.177

2.  Epidemiology and clinical manifestation of HIV infection in northern Zaire.

Authors:  W Strecker; L Gürtler; M Schilling; M Binibangili; K Strecker
Journal:  Eur J Epidemiol       Date:  1994-02       Impact factor: 8.082

3.  Spatial and socio-behavioral patterns of HIV prevalence in the Democratic Republic of Congo.

Authors:  Jane P Messina; Michael Emch; Jeremie Muwonga; Kashamuka Mwandagalirwa; Samuel B Edidi; Nicaise Mama; Augustin Okenge; Steven R Meshnick
Journal:  Soc Sci Med       Date:  2010-08-05       Impact factor: 4.634

4.  HIV1 infection in extra-European students in Turin (Italy): epidemiologic pattern and risk factors.

Authors:  B Adele; Z Carla; M R Angela
Journal:  Eur J Epidemiol       Date:  2000-02       Impact factor: 8.082

5.  AIDS in Africans living in London.

Authors:  N O'Farrell; R Lau; K Yoganathan; C S Bradbeer; G E Griffin; A L Pozniak
Journal:  Genitourin Med       Date:  1995-12

6.  Knowledge and Behavioural Factors Associated with Gender Gap in Acquiring HIV Among Youth in Uganda.

Authors:  Shraboni Patra; Rakesh Kumar Singh
Journal:  J Public Health Res       Date:  2015-07-16

7.  Oral manifestations and their correlation to baseline CD4 count of HIV/AIDS patients in Ghana.

Authors:  Paul Frimpong; Emmanuel Kofi Amponsah; Jacob Abebrese; Soung Min Kim
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2017-02-20

8.  Role of survey response rates on valid inference: an application to HIV prevalence estimates.

Authors:  Miguel Marino; Marcello Pagano
Journal:  Emerg Themes Epidemiol       Date:  2018-03-05

9.  Non-consensual sex and association with incident HIV infection among women: a cohort study in rural Uganda, 1990-2008.

Authors:  Isolde Birdthistle; Billy N Mayanja; Dermot Maher; Sian Floyd; Janet Seeley; Helen A Weiss
Journal:  AIDS Behav       Date:  2013-09

10.  Relationships between CD4+ Counts and the Presence of Oral Lesions in Human Immunodeficiency Virus Positive Women in Nigeria.

Authors:  M Okoh; Bd Saheeb; Ga Agbelusi; Fo Omoregie
Journal:  Ann Med Health Sci Res       Date:  2014-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.